Lab Director Consulting: Offering Contract Consulting to set up and pass CLIA Inspection.  After CLIA certification, a consulting Director is available to sign reports, validate SOP’s, and perform necessary QA/QC operations.

 

Test Development and Bioinformatics: Consulting development of new tests and products based on target market or established customer base. This aligns with a market analysis detailing the current opportunities for test expansion and introduction into new markets.

Strategy: CGC understands the genomics and complex testing market.  With access to data and trends, we can present deliverables to solidify your future strategies. Starting from a detailed competitive and market analysis, you will receive a comprehensive “Where We Stand Today, Where we will Stand Tomorrow” Report. It will detail trends in the market, regional, national and payer based that will affect you over the next 5 to 10 year period.  Reports will also analyze current pipelines in pharmaceuticals and 510k Testing that may directly impact customer base.

In Addition, with collaboration on the Test Development Team, CGC will provide direction in finding the best portfolio of testing that will lead to an increase in your business.

Sales and Marketing  Support/Strategy. CGC can offer support of your future business expansion, including in the developing messaging, deliverables and content for both internal and customer facing interactions. With CGC support, create training modules to actively educate your business team to effectively position and sell your products while maintaining an “On Message” approach. Deeply integrate your business through multiple layers of media and channels that will increase exposure and open opportunites for your sales and outreach efforts.

 

EMR Genomic Data Integration: Integrating complex genomic variant information into a commercial EMR system that offers a privatized and HIPPAA compliant method to deliver pertinent data directed by diagnostic testing but also iincidental information gleened from large scale genomic profiling.